Related Experiment Videos
Hormonal imbalances and thyroid cancers in humans
1Servizio di Epidemiologia, Centro di Riferimento Oncologico, Aviano, PN, Italy.
IARC Scientific Publications
|August 24, 1999
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Trends in thyroid function testing, neck ultrasound, thyroid fine needle aspiration, and thyroidectomies in North-eastern Italy.
Journal of endocrinological investigation·2021
Blood transfusion history and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis.
Cancer causes & control : CCC·2019
Hepatitis B virus-related cryogobulinemic vasculitis. The role of antiviral nucleot(s)ide analogues: a review.
Journal of internal medicine·2019
Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5.
European journal of cancer (Oxford, England : 1990)·2017
Practical approaches to control mycotoxins.
IARC scientific publications·2013
Economics of mycotoxins: evaluating costs to society and cost-effectiveness of interventions.
IARC scientific publications·2013
Risk assessment and risk management of mycotoxins.
IARC scientific publications·2013
Mycotoxins and human health.
IARC scientific publications·2013
Effects in food-producing animals.
IARC scientific publications·2013
Analysis of mycotoxins.
IARC scientific publications·2013
Clinical Research on Microecological Landscape for Infection Risk Stratification in Newly Diagnosed Patients with Hematological Conditions.
Infectious diseases and therapy·2026
Resection of hemorrhagic intracranial testicular choriocarcinoma metastasis with a novel camera-suction device: A surgical case report.
Surgical neurology international·2026
The profile of pleural effusions in oncological patients referred to the cardiothoracic surgery department in a tertiary hospital in Pretoria, South Africa: A retrospective study.
African journal of thoracic and critical care medicine·2026
Macrophage NPM1 drives anti-tumor immunity via the STAT3-CCRL2 axis.
Frontiers in immunology·2026